Some Newer Antiseizure Meds Safer During Pregnancy

Follow Drugslib on

By Dennis Thompson HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

THURSDAY, July 17, 2025 — Some newer antiseizure medications appear to be safer for pregnant women to take without risk of birth defects, a new study says.

Second-generation antiseizure drugs like levetiracetam, oxcarbazepine, gabapentin and zonisamide did not show an increased risk for birth defects, researchers reported July 16 in the journal Neurology.

On the other hand, the study confirmed the known risk of birth defects found in older antiseizure meds, and found risk in some newer drugs.

"Our results confirm that using valproate, phenobarbital or topiramate during early pregnancy is linked to a higher chance of major birth defects in the infants when compared to lamotrigine,” a second-gen drug used as a risk reference, lead researcher Dr. Sonia Hernandez-Diaz, a professor of epidemiology with the Harvard T.H. Chan School of Public Health in Boston, said in a news release.

Women taking valproate had more than five times the risk of birth defects compared to those on lamotrigine, results show. Women taking phenobarbital had nearly three times the risk, and those on topiramate had over twice the risk.

These results are important, given that it’s crucial to keep seizures caused by epilepsy and other conditions under control during pregnancy, Hernandez-Diaz said.

“Seizures can lead to falls and other complications during pregnancy, so seizure control for those with epilepsy is crucial to protect the health of both the mother and child,” she said.

“While some older drugs are known to increase the risk of major malformations, less is known about the safety of newer ‘second generation’ medications,” Hernandez-Diaz said.

For the study, researchers tracked the pregnancies of more than 7,300 women taking an antiseizure drug, and compared them to more than 1,300 women not on the meds.

They looked for evidence of birth defects, including cleft lip, larger-than-normal holes in the heart, spinal cord issues, missing or underdeveloped limbs, and other problems where parts of the body didn’t form correctly.

Risk of major birth defects varied among the drugs. Valproate had the highest risk, with birth defects in 9% of infants exposed, followed by phenobarbital at 6%.

Among newer drugs, birth defects occurred in 5% of babies exposed to topiramate and 2% of those exposed to lamotrigine, results show.

“Our results did not show an increased risk with medications like levetiracetam, oxcarbazepine, gabapentin and zonisamide,” Hernandez-Diaz said. “For lacosamide and pregabalin, the data wasn’t clear enough to make solid conclusions, so more research is needed."

The results provide “valuable information for health care providers and people who may become pregnant to make more informed decisions about the use of these medications during pregnancy,” she concluded.

Sources

  • American Academy of Neurology, news release, July 16, 2025

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-07-18 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords